(Q35170927)

6 August 2017

1 reference

title

Monoclonal gammopathies of undetermined significance: a review (English)

1 reference

6 August 2017

Robert A Kyle

1

1 reference

6 August 2017

S Vincent Rajkumar

series ordinal

2

1 reference

6 August 2017

publication date

1 August 2003

1 reference

6 August 2017

published in

Immunological Reviews

1 reference

6 August 2017

volume

194

1 reference

6 August 2017

page(s)

112-139

1 reference

Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Cancer risk in patients with monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Monoclonal gammopathy in Iceland: a population-based registry and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Role of Helicobacter pylori infection in the incidence and clinical course of monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Helicobacter pylori infection and monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Usefulness and reproducibility of cytomorphologic evaluations to differentiate myeloma from monoclonal gammopathies of unknown significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Telomerase activity in plasma cell dyscrasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Changing clinical presentation of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

A prognostic index for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

The spectrum of IgM monoclonal gammopathy in 430 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Monoclonal proteins in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Myeloma and monoclonal gammopathy of uncertain significance associated with acquired von Willebrand's syndrome. Seven new cases with a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Neuropathies associated with monoclonal gammopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Monoclonal gammopathy and neuropathy: myelin-associated glycoprotein reactivity and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Polyneuropathies associated with IgM monoclonal gammopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

POEMS syndrome: definitions and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Pyoderma gangrenosum associated with severe oropharyngeal involvement and IgA paraproteinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Necrobiotic xanthogranuloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Diffuse plane normolipaemic xanthomatosis in a patient with chronic lymphatic leukaemia and monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Monoclonal gammopathy in Sézary syndrome. Report of three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Cytomegalovirus infection is a trigger for monoclonal immunoglobulins in paediatric kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Paraproteinemic crystalline keratopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Thalidomide for previously untreated indolent or smoldering multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Overestimation of monoclonal immunoglobulin by immunochemical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Chromosomal abnormalities in systemic amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Frequency of pathological proteins (M-components) om 6,995 sera from an adult population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Monoclonal gammopathies in human aging: increased occurrence with age and correlation with health status

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Occurrence of serum M-protein species in Japanese patients older than 50 years based on relative mobility in cellulose acetate membrane electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

A 20-year follow-up study of 64 subjects with M-components

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

The significance of monoclonal gammopathy in a normal population

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

IgH Translocations in Multiple Myeloma: A Nearly Universal Event that Rarely Involves c-myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Monoclonal gammopathy of undetermined significance predisposing to Helicobacter pylori-related gastric mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

"Benign" monoclonal gammopathy--after 20 to 35 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Diagnostic value of the concentration of M-component in initial classification of monoclonal gammopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Bence Jones proteinuria in benign monoclonal gammapathies. Incidence and characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Magnetic resonance appearance of monoclonal gammopathies of unknown significance and multiple myeloma. The GRI Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Triclonal gammopathy and malignant immunoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Monoclonal IgG gammopathy and hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Primary hyperparathyroidism and monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Prevalence of monoclonal gammopathy in patients with primary hyperparathyroidism: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Diagnostic criteria for electrophoretic patterns of serum and urinary proteins in multiple myeloma. Study of one hundred and sixtyfive multiple myeloma patients and of seventy-seven nonmyeloma patients with similar electrophoretic patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Prevalence of monoclonal protein in peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Neuropathies associated with paraproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Monoclonal gammopathy of the immunoglobulin A class in a two-year-old girl with ataxia telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Oligo-/monoclonal gammopathy and hypergammaglobulinemia in ataxia-telangiectasia. A study of 90 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Osteosclerotic myeloma and peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Paraproteinemias in homosexual men with HIV infection. Lack of association with abnormal clinical or immunologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

T-cell immune defect and B-cell activation in renal transplant recipients with monoclonal gammopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Prevalence of monoclonal immunoglobulins after liver transplantation: relationship with posttransplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Monoclonal gammopathy in heart transplantation: risk factor analysis and relevance of immunosuppressive load

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Monoclonal gammopathy of undetermined significance and exposure to breast implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Monoclonal gammopathy in chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Incidence of corneal crystals in the monoclonal gammopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Monoclonal gammopathies of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

Monoclonal gammopathy of undetermined significance. Natural history in 241 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Monoclonal gammopathies in the adult population of Finistère, France

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Evaluation of monoclonal gammopathies in the "well" elderly

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Retrospective cohort study of 148 patients with polyclonal gammopathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Review of 1027 patients with newly diagnosed multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

The physiopathological significance of benign monoclonal gammopathy: a study of 64 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Malignant transformation of monoclonal gammopathy of undetermined significance among out‐patients of a community hospital in Southeastern Netherlands

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

The natural history of monoclonal gammopathy of undetermined significance. A 5- to 20-year follow-up of 263 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Malignant transformation of monoclonal gammopathy of undetermined significance: cumulative incidence and prognostic factors.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Monoclonal gammopathy of undetermined significance: chromosome changes are a common finding within bone marrow plasma cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Transplacental carcinogenesis by stilbestrol

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Bone marrow angiogenesis and progression in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Biology of osteoclast activation in cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Biology of the Transition of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

The role of interleukin-1 beta in the pathogenesis of multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Presenting features of monoclonal gammopathies: an analysis of 684 newly diagnosed cases. Cooperative Group for the Study and Treatment of Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Multiple myeloma or benign monoclonal gammopathy? A study of differential diagnostic criteria in 44 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Smoldering multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Risk of disease progression in asymptomatic multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Has the incidence of multiple myeloma in old age been underestimated? The myeloma project of health region I in Norway. I

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Prognostic features of asymptomatic multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I--a randomized study. Myeloma Group of Western Sweden

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

The clinical aspects of biclonal gammopathies. Review of 57 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Double gammopathies: incidence and clinical course of 20 patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Triclonal gammopathy (IgAk, IgGk, and IgMk) in a patient with plasmacytoid lymphoma derived from a monoclonal origin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Idiopathic bence jones proteinuria—A distinct entity?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

"Idiopathic" Bence Jones proteinuria: long-term follow-up in seven patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Immunoglobulin D benign monoclonal gammopathy. A case report

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

IgD monoclonal gammopathy with long-term follow-up

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Malignant lymphoma and lymphatic leukemia associated with myeloma-type serum proteins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Paraproteinaemia plus osteolytic lesions in typical hairy-cell leukaemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Prevalence of monoclonal Ig with lambda light chains in chronic myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

An unusual association of monoclonal gammopathy, paroxysmal nocturnal haemoglobinuria and myelodysplastic syndrome transformed into acute myeloid leukaemia: coexistence of triple clonal disorders.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Coagulation disorders in patients with monoclonal gammopathies.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Rheumatoid arthritis, dysproteinemic arthropathy, and paraproteinemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Thirty cases of monoclonal immunoglobulin disorders other than myeloma or macroglobulinemia. A classification of diseases associated with the production of monoclonal-type immunoglobulins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Monoclonal gammopathy in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Ankylosing spondylitis and monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

IgG monoclonal gammopathy in four patients with polymyalgia rheumatica

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Inclusion body myositis and paraproteinemia: Incidence and immunopathologic correlations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Peripheral neuropathy in IgM monoclonal gammopathy and Wäldenstrom's macroglobulinemia: a frequent complication in elderly males with low MAG-reactive serum monoclonal component.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Neuropathy associated with monoclonal gammopathies of undetermined significance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Plasmapheresis alleviates neuropathy accompanying IgM anti-myelin-associated glycoprotein paraproteinemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Plasma-exchange in chronic peripheral neurological disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Successful treatment of IgM paraproteinaemic neuropathy with fludarabine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Long term melphalan-prednisolone chemotherapy for POEMS syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Rapidly progressive renal failure occurring in the course of pyoderma gangrenosum and IgA (lambda) monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Necrobiotic xanthogranuloma with paraproteinemia. A review of 22 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Cytotoxic effect of serum on fibroblasts in one case of normolipidemic plane xanthoma and myeloma IgG lambda

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Monoclonal gammopathies and associated skin disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Monoclonal gammopathy and mycosis fungoides. Report of four cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Kaposi's sarcoma and monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Erythema elevatum diutinum associated with Wegener's granulomatosis and IgA paraproteinemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Prospective follow-up of monoclonal gammopathies in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Monoclonal gammopathies in HBsAg-positive patients with renal transplants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Monoclonal gammapathies in patients undergoing immunosuppressive treatment after renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Frequent occurrence of monoclonal gammopathies with an imbalanced light-chain ratio following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

CMV infection after allogeneic bone marrow transplantation is associated with the occurrence of various autoantibodies and monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Benign monoclonal gammopathy turning to AL amyloidosis after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Acquired C1 Esterase Inhibitor Deficiency and Angioedema

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Recurrent febrile panniculitis and hepatitis in two patients with acquired complement deficiency and paraproteinemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Control of systemic capillary leak syndrome with aminophylline and terbutaline

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Immunoglobulin G crystalline keratopathy associated with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Corneal deposits as an alerting sign of monoclonal gammopathy: a case report

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

Non symptomatic hypercalcemia in a myeloma patient

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2003.00056.X

7 January 2021

10.1034/J.1600-065X.2003.00056.X

Identifiers

DOI

1 reference

6 August 2017

1 reference